Physician profile
Richard Lawrence Weiner
NPI 1093701872
$225,009.94
in general payments reported to CMS, 2019-2025
26 companies · $12K in 2025
The $12K reported for 2025 was more than what 86% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67K · 2020: $12K · 2021: $23K · 2022: $66K · 2023: $21K · 2024: $24K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $51K · Travel and Lodging: $3,440 · Food and Beverage: $1,582 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $50,852.25 |
| Travel and Lodging | $3,440.24 |
| Food and Beverage | $1,581.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $575.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Life Spine, INC. | $142,050.98 | 2019-2024 | Prolift, Centric - T Retractor, Avatar Minimally Invasive Spinal System |
| Wound Management Technologies, INC | $28,738.22 | 2019 | |
| Sanara Medtech INC. | $23,436.49 | 2020-2024 | Celleraterx |
| Curonix LLC | $10,696.37 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $10,551.37 | 2019-2021 | |
| Stryker Corporation | $5,449.34 | 2024-2025 | Optablate |
| Interventional Pain Technologies INC. | $1,146.52 | 2022 | |
| Spinal Elements, INC. | $854.46 | 2019 | |
| Boston Scientific Corporation | $442.86 | 2019-2020 | |
| Zap Surgical Systems, INC. | $299.43 | 2019-2020 | |
| Medtronic, INC. | $259.86 | 2025 | Synchromedii |
| Nevro Corp. | $212.04 | 2019-2020 | |
| Globus Medical, INC. | $162.10 | 2019 | |
| Innovasis INC | $149.96 | 2021 | |
| Grt US Holding, INC. | $116.66 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $96.89 | 2019 | |
| Kci USA, INC. | $52.83 | 2021 | |
| Spineology INC. | $51.91 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.69 | 2019 | |
| Intrinsic Therapeutics | $49.36 | 2023 | Barricaid Acd (Annular Closure Device) |
| Biotronik Nro, INC. | $43.72 | 2025 | Prospera |
| Sebela Pharmaceuticals INC. | $29.62 | 2019-2020 | |
| Integra Lifesciences Corporation | $23.14 | 2020 | |
| Scilex Pharmaceuticals INC. | $16.05 | 2019 | |
| Mml US, INC. | $15.15 | 2023 | Reactiv8 |
| Gt Medical Technologies, INC | $13.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$25,400.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Weiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.